Sinoway Industrial Co., Ltd.

Who Not Suitable For Pregabalin Who Not Suitable For Pregabalin

Who not suitable for Pregabalin
Pregabalin capsule is a new gamma-aminobutyric acid (GABA) receptor agonist developed by Pfizer. In July 2010, it was listed on the SFDA new batch of China for the treatment of postherpetic neuralgia.

The indications for pregabalin capsules include generalized anxiety disorder, diabetic peripheral neuropathy, post-herpetic neuralgia, fibromyalgia syndrome, and adjuvant therapy of epilepsy.

So, what crowd is not suitable for taking pregabalin capsules?

The indications for pregabalin capsules include generalized anxiety disorder, diabetic peripheral neuropathy, post-herpetic neuralgia, fibromyalgia syndrome, and adjuvant therapy of epilepsy.

This product may cause peripheral edema, heart function III or IV level of patients with congestive heart failure should be used with caution. Dizziness and drowsiness associated with this product may affect the ability to drive or operate the machine. After taking creatine kinase may appear elevated, such as suspected or confirmed as myopathy or creatine kinase increased significantly, should stop using this product. This product may cause physical dependence. Caution for pregnant women, lactating women should stop breast-feeding medication. Patients less than or equal to 17 years of age should not be used.

Because pregabalin is mainly excreted in urine in the form of a prototype drug, the metabolism of this product in the human body can be neglected. Ex vivo studies showed that pregabalin did not inhibit drug metabolism nor did it bind to plasma proteins, and pregabalin had little pharmacokinetic interaction with other drugs.
Related Products
Related Blog
  • TEL:+86-0592-5854962
  • FAX:+86-0592-5854960
  • EMAIL: xie@china-sinoway.com
  • ADDRESS:Floor 16, Huicheng Business Center, No. 839, Xiahe Rd., Siming Dist. Xiamen, Fujian, China
//